Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency

Area of Science:

• Nephrology
• Endocrinology
• Lipid Metabolism

Background:

• Renal insufficiency is associated with dyslipoproteinaemia, but the specific lipoprotein alterations in early stages are not fully characterized.
• Understanding these changes is crucial for assessing cardiovascular risk in patients with chronic kidney disease.

Purpose of the Study:

• To characterize plasma lipid and apolipoprotein profiles in patients with early renal insufficiency.
• To investigate the relationship between lipoprotein abnormalities and markers of metabolic derangement like insulin and parathyroid hormone (PTH).

Main Methods:

• Cross-sectional study comparing normotriglyceridaemic (NTG) and hypertriglyceridaemic (HTG) patients with moderate renal impairment (GFR 20-55 ml/min) to controls.
• Analysis of plasma lipid profiles, apolipoproteins (apoA-I, apoB, apoC-III, apoE), insulin, and PTH.
• Calculation of key apolipoprotein ratios, including apoA-I/apoC-III and apoA-I/apoB.

Main Results:

• NTG and HTG patients exhibited significantly increased plasma concentrations of apoC-III and apoB compared to controls.
• The apoA-I/apoC-III ratio, a marker of renal dyslipoproteinaemia, was markedly reduced in both NTG and HTG groups.
• HTG patients showed a fourfold increase of apoC-III in VLDL-LDL fractions, while NTG patients had increased apoC-III in both VLDL-LDL and HDL.
• Plasma insulin and PTH levels correlated with the apoA-I/apoC-III ratio, independent of GFR and BMI.

Conclusions:

• Early renal insufficiency is characterized by specific lipoprotein abnormalities, including elevated apoC-III and apoB and a reduced apoA-I/apoC-III ratio.
• These lipoprotein changes are more pronounced in hypertriglyceridaemic patients.
• PTH-mediated alterations in insulin metabolism may play a role in the pathogenesis of renal dyslipoproteinaemia.